Related Experiment Video
Updated: Jun 30, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Phenobarbital-Induced Toxic Epidermal Necrolysis: A Case Report
Biniyam Tedla Mamo1, Solomon Getnet Meshesha1, Zelalem Aysheshim Andualem1
1Ethiopian Food and Drug Administration Addis Ababa Ethiopia.
Clinical Case Reports
|June 29, 2026
Summary
Phenobarbital can cause severe adverse drug reactions like toxic epidermal necrolysis, a rare medical emergency. Prompt recognition and management are crucial for patient safety and improved outcomes.
Area of Science:
- Pharmacology
- Dermatology
- Pediatrics
Background:
- Adverse drug reactions (ADRs) contribute to significant morbidity and mortality.
- Phenobarbital, an anti-epileptic, is associated with severe ADRs, including toxic epidermal necrolysis (TEN).
- TEN is a rare but life-threatening dermatological emergency.
Purpose of the Study:
- To report a case of phenobarbital-induced toxic epidermal necrolysis in a pediatric patient.
- To highlight the clinical presentation and management of this severe ADR.
- To emphasize the importance of early recognition and intervention.
Main Methods:
- A six-year-old female epileptic patient presented with extensive exfoliative lesions.
- Clinical examination revealed diffuse skin and mucosal involvement (90% body surface area), fever, ocular, and oropharyngeal symptoms.
- Management included phenobarbital withdrawal, IV antibiotics, systemic corticosteroids, wound care, analgesia, and nutritional support.
Main Results:
- The patient exhibited severe skin exfoliation and systemic symptoms indicative of TEN.
- Withdrawal of phenobarbital and comprehensive supportive care were initiated.
- The case underscores the critical nature of phenobarbital-induced TEN.
Conclusions:
- Early identification and cessation of the offending drug (phenobarbital) are paramount in managing TEN.
- Prompt and aggressive multidisciplinary management is essential for improving patient outcomes.
- Increased awareness of phenobarbital-induced ADRs is vital for pediatric patient safety.
Related Concept Videos
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...